Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2011

01.09.2011 | Review

Pregnancy after breast cancer: if you wish, ma’am

verfasst von: Olivia Pagani, Ann Partridge, Larissa Korde, Sunil Badve, John Bartlett, Kathy Albain, Richard Gelber, Aron Goldhirsch

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

A growing number of young breast cancer survivors consider reproductive health issues, including subsequent fertility and pregnancy, of great importance, but many questions regarding safety remain unanswered. We conducted a comprehensive literature search and review of published articles, control-matched, population-based, and co-operative group reports that addressed various aspects of pregnancy after breast cancer (patients’ expectations, fertility damage, assessment and preservation, maternal and fetal outcome, breast feeding). Overall, available data support pregnancy and breast feeding after breast cancer as safe and feasible for women at low risk of recurrence. This retrospective and population-based evidence is, however, frequently incomplete; usually not representative of the entire population, it can be biased by patients’ related effects or underpowered and is often not controlled for biological factors and risk determinants in the statistical model used. Before making any definitive assumption on this delicate and fundamental aspect of a woman’s life after breast cancer, we should demonstrate without any reasonable doubt that the scattered information available today is scientifically sound. The Breast International Group and North American Breast Cancer Group are planning a global prospective study in young women with endocrine responsive, early breast cancer who desire pregnancy, to assess both patients’ and pregnancy outcomes. The trial will include an observational phase investigating the feasibility and impact of a temporary treatment interruption to allow conception and an experimental phase investigating the optimal duration of the subsequent endocrine treatment after delivery or the last failed attempt to get pregnant.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Brinton LA, Sherman ME, Carreon JD, Anderson WF (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100(22):1643–1648PubMedCrossRef Brinton LA, Sherman ME, Carreon JD, Anderson WF (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100(22):1643–1648PubMedCrossRef
2.
Zurück zum Zitat Goldhirsch A, Gelber RD (2004) Breast cancer in young women. In: Harris JR, Lippman ME, Morrow M et al (eds) Diseases of the breast, 3rd edn. Lippincott Williams & Wilkins, MD, pp 1339–1349 Goldhirsch A, Gelber RD (2004) Breast cancer in young women. In: Harris JR, Lippman ME, Morrow M et al (eds) Diseases of the breast, 3rd edn. Lippincott Williams & Wilkins, MD, pp 1339–1349
3.
Zurück zum Zitat Kroman N, Jensen MB, Wohlfahrt J et al (2000) Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 320:474–478PubMedCrossRef Kroman N, Jensen MB, Wohlfahrt J et al (2000) Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 320:474–478PubMedCrossRef
5.
Zurück zum Zitat Anders CK, Hsu DS, Broadwater G et al (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26:3324–3330PubMedCrossRef Anders CK, Hsu DS, Broadwater G et al (2008) Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 26:3324–3330PubMedCrossRef
6.
Zurück zum Zitat Sant M, Allemani C, Berrino F (2004) European concerted action on survival and care of cancer patients (EUROCARE) working group. Breast carcinoma survival in Europe and the United States. Cancer 100(4):715–722PubMedCrossRef Sant M, Allemani C, Berrino F (2004) European concerted action on survival and care of cancer patients (EUROCARE) working group. Breast carcinoma survival in Europe and the United States. Cancer 100(4):715–722PubMedCrossRef
7.
Zurück zum Zitat Cancello G, Maisonneuve P, Rotmensz N et al (2010) Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol 21(10):1974–1981PubMedCrossRef Cancello G, Maisonneuve P, Rotmensz N et al (2010) Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol 21(10):1974–1981PubMedCrossRef
8.
Zurück zum Zitat Smigal C, Jemal A, Ward E et al (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56:168–183PubMedCrossRef Smigal C, Jemal A, Ward E et al (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56:168–183PubMedCrossRef
9.
Zurück zum Zitat Romond EH, Perez EA, Bryant J et al (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353:1673–1684PubMedCrossRef Romond EH, Perez EA, Bryant J et al (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353:1673–1684PubMedCrossRef
10.
Zurück zum Zitat Smith I, Procter M, Gelber RD et al (2007) 2-Year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet 369(9555):29–36PubMedCrossRef Smith I, Procter M, Gelber RD et al (2007) 2-Year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet 369(9555):29–36PubMedCrossRef
11.
Zurück zum Zitat Ventura SJ, Abma JC, Mosher WD, Henshaw SK (2008) Estimated pregnancy rates by outcome for the United States, 1990–2004. National Center for Health Statistics. Natl Vital Stat Rep 56(15):1–25PubMed Ventura SJ, Abma JC, Mosher WD, Henshaw SK (2008) Estimated pregnancy rates by outcome for the United States, 1990–2004. National Center for Health Statistics. Natl Vital Stat Rep 56(15):1–25PubMed
12.
Zurück zum Zitat Prioux F (2005) Late fertility in Europe: some comparative and historical data. Rev Epidemiol Sante Publique 53(2):2S3–2S11PubMed Prioux F (2005) Late fertility in Europe: some comparative and historical data. Rev Epidemiol Sante Publique 53(2):2S3–2S11PubMed
13.
Zurück zum Zitat Heck KE, Schoendorf KC, Ventura SJ, Kiely JL (1997) Delayed childbearing by education level in the United States, 1969–1994. Matern Child Health J 1(2):81–88PubMedCrossRef Heck KE, Schoendorf KC, Ventura SJ, Kiely JL (1997) Delayed childbearing by education level in the United States, 1969–1994. Matern Child Health J 1(2):81–88PubMedCrossRef
14.
Zurück zum Zitat Partridge AH, Gelber S, Peppercorn J et al (2004) Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22:4174–4183PubMedCrossRef Partridge AH, Gelber S, Peppercorn J et al (2004) Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22:4174–4183PubMedCrossRef
15.
Zurück zum Zitat Ruddy KJ, Gelber S, Ginsburg ES et al (2011) Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls. Menopause 18(1):105–108PubMedCrossRef Ruddy KJ, Gelber S, Ginsburg ES et al (2011) Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls. Menopause 18(1):105–108PubMedCrossRef
16.
Zurück zum Zitat Thewes B, Meiser B, Taylor A et al (2005) Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 23:5155–5165PubMedCrossRef Thewes B, Meiser B, Taylor A et al (2005) Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 23:5155–5165PubMedCrossRef
17.
Zurück zum Zitat Duffy CM, Allen SM, Clark MA (2005) Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 23:766–773PubMedCrossRef Duffy CM, Allen SM, Clark MA (2005) Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 23:766–773PubMedCrossRef
19.
Zurück zum Zitat Azim HA, Peccatori FA, de Azambuja E, Piccart MJ (2011) Motherhood after breast cancer: searching for la dolce vita. Expert Rev Anticancer Ther 11(2):287–298PubMedCrossRef Azim HA, Peccatori FA, de Azambuja E, Piccart MJ (2011) Motherhood after breast cancer: searching for la dolce vita. Expert Rev Anticancer Ther 11(2):287–298PubMedCrossRef
20.
Zurück zum Zitat de Bree E, Makrigiannakis A, Askoxylakis J (2010) Pregnancy after breast cancer. A comprehensive review. J Surg Oncol 101(6):534–542PubMedCrossRef de Bree E, Makrigiannakis A, Askoxylakis J (2010) Pregnancy after breast cancer. A comprehensive review. J Surg Oncol 101(6):534–542PubMedCrossRef
21.
Zurück zum Zitat Azim HA Jr, Santoro S, Pavlidis N et al (2011) Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. EJC 47(1):74–83CrossRef Azim HA Jr, Santoro S, Pavlidis N et al (2011) Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. EJC 47(1):74–83CrossRef
22.
Zurück zum Zitat Mueller BA, Simon MS, Deapen D et al (2003) Childbearing and survival after breast carcinoma in young women. Cancer 98(6):1131–1140PubMedCrossRef Mueller BA, Simon MS, Deapen D et al (2003) Childbearing and survival after breast carcinoma in young women. Cancer 98(6):1131–1140PubMedCrossRef
23.
Zurück zum Zitat Sankila R, Heinavaara S, Hakulinen T (1994) Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect”. Am J Obstet Gynecol 170:818–823PubMed Sankila R, Heinavaara S, Hakulinen T (1994) Survival of breast cancer patients after subsequent term pregnancy: “healthy mother effect”. Am J Obstet Gynecol 170:818–823PubMed
24.
Zurück zum Zitat Rajkumar L, Guzman RC, Yang J et al (2004) Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. Breast Cancer Res 6(1):R31–R37PubMedCrossRef Rajkumar L, Guzman RC, Yang J et al (2004) Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. Breast Cancer Res 6(1):R31–R37PubMedCrossRef
25.
Zurück zum Zitat Yuri T, Tsukamoto R, Miki K et al (2006) Biphasic effects of zerona on the growth of estrogen receptor-positive human breast carcinoma cells. Oncol Rep 16(6):1307–1312PubMed Yuri T, Tsukamoto R, Miki K et al (2006) Biphasic effects of zerona on the growth of estrogen receptor-positive human breast carcinoma cells. Oncol Rep 16(6):1307–1312PubMed
26.
Zurück zum Zitat Janerich DT (2001) The fetal antigen hypothesis: cancers and beyond. Med Hypotheses 56(1):101–103PubMedCrossRef Janerich DT (2001) The fetal antigen hypothesis: cancers and beyond. Med Hypotheses 56(1):101–103PubMedCrossRef
27.
Zurück zum Zitat Andrieu N, Goldgar DE, Easton DF et al (2006) Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). JNCI 98(8):535–544PubMed Andrieu N, Goldgar DE, Easton DF et al (2006) Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). JNCI 98(8):535–544PubMed
28.
Zurück zum Zitat Del Mastro L, Catzeddu T, Venturini M (2006) Infertility and pregnancy after breast cancer: current knowledge and future perspectives. Cancer Treat Rev 32(6):417–422PubMedCrossRef Del Mastro L, Catzeddu T, Venturini M (2006) Infertility and pregnancy after breast cancer: current knowledge and future perspectives. Cancer Treat Rev 32(6):417–422PubMedCrossRef
29.
Zurück zum Zitat Ives A, Saunders C, Bulsara M, Semmens J (2007) Pregnancy after breast cancer: population based study. BMJ 334(7586):194–198PubMedCrossRef Ives A, Saunders C, Bulsara M, Semmens J (2007) Pregnancy after breast cancer: population based study. BMJ 334(7586):194–198PubMedCrossRef
30.
Zurück zum Zitat Partridge AH, Gelber S, Peppercorn J et al (2008) Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer 8(1):65–69PubMedCrossRef Partridge AH, Gelber S, Peppercorn J et al (2008) Fertility and menopausal outcomes in young breast cancer survivors. Clin Breast Cancer 8(1):65–69PubMedCrossRef
31.
Zurück zum Zitat Walshe JM, Denduluri N, Swain SM (2006) Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 24(36):5769–5779PubMedCrossRef Walshe JM, Denduluri N, Swain SM (2006) Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 24(36):5769–5779PubMedCrossRef
32.
Zurück zum Zitat Faddy MJ, Gosden RG (1995) A mathematical model of follicle dynamics in the human ovary. Hum Reprod 10:770–775PubMed Faddy MJ, Gosden RG (1995) A mathematical model of follicle dynamics in the human ovary. Hum Reprod 10:770–775PubMed
33.
Zurück zum Zitat Partridge AH, Ruddy KJ (2007) Fertility and adjuvant treatment in young women with breast cancer. Breast 16(S2):S175–S181PubMedCrossRef Partridge AH, Ruddy KJ (2007) Fertility and adjuvant treatment in young women with breast cancer. Breast 16(S2):S175–S181PubMedCrossRef
34.
Zurück zum Zitat Oktay K, Sönmezer M (2008) Fertility issues and options in young women with cancer. Recent Results Cancer Res 178:203–224PubMedCrossRef Oktay K, Sönmezer M (2008) Fertility issues and options in young women with cancer. Recent Results Cancer Res 178:203–224PubMedCrossRef
35.
Zurück zum Zitat Jung M, Shin H, Rha S et al (2010) The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up. Ann Surg Oncol 17(12):3259–3268PubMedCrossRef Jung M, Shin H, Rha S et al (2010) The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up. Ann Surg Oncol 17(12):3259–3268PubMedCrossRef
36.
Zurück zum Zitat Abusief ME, Missmer SA, Ginsburg ES et al (2010) The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer 116(4):791–798PubMedCrossRef Abusief ME, Missmer SA, Ginsburg ES et al (2010) The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer 116(4):791–798PubMedCrossRef
37.
Zurück zum Zitat Partridge A, Gelber S, Gelber RD et al (2007) Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from international breast cancer study group trials V and VI. EJC 43:1646–1653CrossRef Partridge A, Gelber S, Gelber RD et al (2007) Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from international breast cancer study group trials V and VI. EJC 43:1646–1653CrossRef
38.
Zurück zum Zitat Partridge AH, Ruddy KJ, Gelber S et al (2010) Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril 94(2):638–644PubMedCrossRef Partridge AH, Ruddy KJ, Gelber S et al (2010) Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril 94(2):638–644PubMedCrossRef
39.
Zurück zum Zitat Kroman N, Jensen MB, Melbye M et al (1997) Should women be advised against pregnancy after breast cancer treatment? Lancet 350:319–322PubMedCrossRef Kroman N, Jensen MB, Melbye M et al (1997) Should women be advised against pregnancy after breast cancer treatment? Lancet 350:319–322PubMedCrossRef
40.
Zurück zum Zitat Velentgas P, Daling JR, Malone KE et al (1999) Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer 85:2424–2432PubMedCrossRef Velentgas P, Daling JR, Malone KE et al (1999) Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer 85:2424–2432PubMedCrossRef
41.
Zurück zum Zitat Gelber S, Coates AS, Goldhirsch A et al (2001) Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 19:1671–1675PubMed Gelber S, Coates AS, Goldhirsch A et al (2001) Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 19:1671–1675PubMed
42.
Zurück zum Zitat Blakely LJ, Buzdar AU, Lozada JA et al (2004) Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 100(3):465–469PubMedCrossRef Blakely LJ, Buzdar AU, Lozada JA et al (2004) Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence. Cancer 100(3):465–469PubMedCrossRef
43.
Zurück zum Zitat Langagergaard V, Gislum M, Skriver MV et al (2006) Birth outcome in women with breast cancer. Br J Cancer 94(1):142–146PubMedCrossRef Langagergaard V, Gislum M, Skriver MV et al (2006) Birth outcome in women with breast cancer. Br J Cancer 94(1):142–146PubMedCrossRef
44.
Zurück zum Zitat Dalberg K, Eriksson J, Holmberg L (2006) Birth outcome in women with previously treated breast cancer–a population-based cohort study from Sweden. PLoS Med 3(9):e336PubMedCrossRef Dalberg K, Eriksson J, Holmberg L (2006) Birth outcome in women with previously treated breast cancer–a population-based cohort study from Sweden. PLoS Med 3(9):e336PubMedCrossRef
45.
Zurück zum Zitat Lee SJ, Schover LR, Partridge AH et al (2006) American Society of Clinical Oncology: American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917–2931PubMedCrossRef Lee SJ, Schover LR, Partridge AH et al (2006) American Society of Clinical Oncology: American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917–2931PubMedCrossRef
46.
Zurück zum Zitat Lee S, Ozkavukcu S, Heytens E, Moy F, Oktay K (2010) Value of early referral to fertility preservation in young women with breast cancer. J Clin Oncol 28(31):4683–4686PubMedCrossRef Lee S, Ozkavukcu S, Heytens E, Moy F, Oktay K (2010) Value of early referral to fertility preservation in young women with breast cancer. J Clin Oncol 28(31):4683–4686PubMedCrossRef
47.
Zurück zum Zitat Porcu E, Bazzocchi A, Notarangelo L et al (2008) Human oocyte cryopreservation in infertility and oncology. Curr Opin Endocrinol, Diabetes Obesity 15:529–535CrossRef Porcu E, Bazzocchi A, Notarangelo L et al (2008) Human oocyte cryopreservation in infertility and oncology. Curr Opin Endocrinol, Diabetes Obesity 15:529–535CrossRef
48.
Zurück zum Zitat Oktay K, Buyuk E, Rodriguez-Wallberg KA, Sahin G (2010) In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod Biomed Online 20(5):634–638PubMedCrossRef Oktay K, Buyuk E, Rodriguez-Wallberg KA, Sahin G (2010) In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reprod Biomed Online 20(5):634–638PubMedCrossRef
49.
Zurück zum Zitat Oktay K, Buyuk E, Libertella N et al (2005) Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23:4347–4353PubMedCrossRef Oktay K, Buyuk E, Libertella N et al (2005) Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23:4347–4353PubMedCrossRef
50.
Zurück zum Zitat West ER, Shea LD, Woodruff TK (2007) Engineering the follicle microenvironment. Semin Reprod Med 25(4):287–299PubMedCrossRef West ER, Shea LD, Woodruff TK (2007) Engineering the follicle microenvironment. Semin Reprod Med 25(4):287–299PubMedCrossRef
51.
Zurück zum Zitat Donaldson SS, Link MP, Weinstein HJ et al (2007) Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low risk Hodgkin’s disease. J Clin Oncol 25:332–337PubMedCrossRef Donaldson SS, Link MP, Weinstein HJ et al (2007) Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low risk Hodgkin’s disease. J Clin Oncol 25:332–337PubMedCrossRef
52.
Zurück zum Zitat Blumenfeld Z, Avivi I, Eckman A et al (2008) Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril 89:166–173PubMedCrossRef Blumenfeld Z, Avivi I, Eckman A et al (2008) Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma. Fertil Steril 89:166–173PubMedCrossRef
53.
Zurück zum Zitat Beck-Fruchter R, Weiss A, Shalev E (2008) GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum Reprod Update 14:553–561PubMedCrossRef Beck-Fruchter R, Weiss A, Shalev E (2008) GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data. Hum Reprod Update 14:553–561PubMedCrossRef
54.
Zurück zum Zitat Oktay K, Sonmezer M, Oktem O et al (2007) Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 12:1055–1066PubMedCrossRef Oktay K, Sonmezer M, Oktem O et al (2007) Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 12:1055–1066PubMedCrossRef
55.
Zurück zum Zitat Badawy A, Elnashar A, El-Ashry M et al (2009) Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril 91:694–697PubMedCrossRef Badawy A, Elnashar A, El-Ashry M et al (2009) Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril 91:694–697PubMedCrossRef
56.
Zurück zum Zitat Gerber B, von Minckwitz G, Stehle H et al (2011) Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol 29(17):2334–2341PubMedCrossRef Gerber B, von Minckwitz G, Stehle H et al (2011) Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol 29(17):2334–2341PubMedCrossRef
57.
Zurück zum Zitat Anderson RA, Cameron DA (2011) Pre-treatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab 96(5):1336–1343PubMedCrossRef Anderson RA, Cameron DA (2011) Pre-treatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab 96(5):1336–1343PubMedCrossRef
58.
Zurück zum Zitat Su HI, Sammel MD, Green J et al (2010) Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer 116(3):592–599PubMedCrossRef Su HI, Sammel MD, Green J et al (2010) Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer 116(3):592–599PubMedCrossRef
59.
Zurück zum Zitat Anderson RA, Themmen APN, Al Qahtani A et al (2006) The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Human Reprod 10:2583–2592CrossRef Anderson RA, Themmen APN, Al Qahtani A et al (2006) The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Human Reprod 10:2583–2592CrossRef
60.
Zurück zum Zitat Scheffer GJ, Broekmans FJ, Looman CW et al (2003) The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 18:700–706PubMedCrossRef Scheffer GJ, Broekmans FJ, Looman CW et al (2003) The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 18:700–706PubMedCrossRef
61.
Zurück zum Zitat Lutchman Singh K, Muttukrishna S, Stein RC et al (2007) Predictors of ovarian reserve in young women with breast cancer. Br J Cancer 96:1808–1816PubMedCrossRef Lutchman Singh K, Muttukrishna S, Stein RC et al (2007) Predictors of ovarian reserve in young women with breast cancer. Br J Cancer 96:1808–1816PubMedCrossRef
62.
Zurück zum Zitat Gorman JR, Usita PM, Madlensky L, Pierce JP (2009) A qualitative investigation of breast cancer survivors’ experiences with breastfeeding. J Cancer Surviv 3:181–191PubMedCrossRef Gorman JR, Usita PM, Madlensky L, Pierce JP (2009) A qualitative investigation of breast cancer survivors’ experiences with breastfeeding. J Cancer Surviv 3:181–191PubMedCrossRef
63.
Zurück zum Zitat McCullough L, Ng A, Najita J et al (2010) Breastfeeding in survivors of Hodgkin lymphoma treated with chest radiotherapy. Cancer 116(20):4866–4871PubMedCrossRef McCullough L, Ng A, Najita J et al (2010) Breastfeeding in survivors of Hodgkin lymphoma treated with chest radiotherapy. Cancer 116(20):4866–4871PubMedCrossRef
64.
Zurück zum Zitat Moran MS, Colasanto JM, Haffty BG et al (2005) Effects of breast-conserving therapy on lactation after pregnancy. Cancer 11:399–403CrossRef Moran MS, Colasanto JM, Haffty BG et al (2005) Effects of breast-conserving therapy on lactation after pregnancy. Cancer 11:399–403CrossRef
65.
Zurück zum Zitat Azim HA Jr, Bellettini G, Gelber S, Peccatori FA (2009) Breast-feeding after breast cancer: if you wish, madam. Breast Cancer Res Treat 114(1):7–12PubMedCrossRef Azim HA Jr, Bellettini G, Gelber S, Peccatori FA (2009) Breast-feeding after breast cancer: if you wish, madam. Breast Cancer Res Treat 114(1):7–12PubMedCrossRef
66.
Zurück zum Zitat Azim HA Jr, Bellettini G, Liptrott SJ et al (2010) Breastfeeding in breast cancer survivors: pattern, behaviour and effect on breast cancer outcome. Breast 19(6):527–531PubMedCrossRef Azim HA Jr, Bellettini G, Liptrott SJ et al (2010) Breastfeeding in breast cancer survivors: pattern, behaviour and effect on breast cancer outcome. Breast 19(6):527–531PubMedCrossRef
67.
Zurück zum Zitat Helewa M, Levesque P, Provencher D et al (2002) Breast Disease Committee and Executive Committee and Council, Society of Obstetricians and Gynaecologists of Canada. Breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can 24(2):164–180PubMed Helewa M, Levesque P, Provencher D et al (2002) Breast Disease Committee and Executive Committee and Council, Society of Obstetricians and Gynaecologists of Canada. Breast cancer, pregnancy, and breastfeeding. J Obstet Gynaecol Can 24(2):164–180PubMed
68.
Zurück zum Zitat Camune B, Gabzdyl E (2007) Breast-feeding after breast cancer in childbearing women. J Perinat Neonat Nurs 21(3):225–233 Camune B, Gabzdyl E (2007) Breast-feeding after breast cancer in childbearing women. J Perinat Neonat Nurs 21(3):225–233
69.
Zurück zum Zitat Rosenberg R, Levy-Schwartz R (2003) Breast cancer in women younger than 40 years. Int J Fertil 48(5):200–205 Rosenberg R, Levy-Schwartz R (2003) Breast cancer in women younger than 40 years. Int J Fertil 48(5):200–205
70.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365:1687–1717CrossRef Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365:1687–1717CrossRef
71.
Zurück zum Zitat Cuzick J, Ambroisine L, Davidson N et al (2007) Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. Lancet 369:1711–1723PubMedCrossRef Cuzick J, Ambroisine L, Davidson N et al (2007) Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. Lancet 369:1711–1723PubMedCrossRef
72.
Zurück zum Zitat International Breast Cancer Study Group (2006) Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group trial 13–93. J Clin Oncol 24:1332–1341CrossRef International Breast Cancer Study Group (2006) Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group trial 13–93. J Clin Oncol 24:1332–1341CrossRef
73.
Zurück zum Zitat Swain SM, Jeong JH, Geyer CE Jr et al (2010) Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 362:2053–2065PubMedCrossRef Swain SM, Jeong JH, Geyer CE Jr et al (2010) Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 362:2053–2065PubMedCrossRef
Metadaten
Titel
Pregnancy after breast cancer: if you wish, ma’am
verfasst von
Olivia Pagani
Ann Partridge
Larissa Korde
Sunil Badve
John Bartlett
Kathy Albain
Richard Gelber
Aron Goldhirsch
Publikationsdatum
01.09.2011
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2011
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-011-1643-7

Weitere Artikel der Ausgabe 2/2011

Breast Cancer Research and Treatment 2/2011 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.